Free Trial
NASDAQ:BTMDW

biote (BTMDW) Stock Price, News & Analysis

biote logo
$0.02 +0.00 (+1.00%)
As of 05/30/2025

About biote Stock (NASDAQ:BTMDW)

Key Stats

Today's Range
$0.02
$0.02
50-Day Range
$0.01
$0.06
52-Week Range
$0.05
$1.68
Volume
59,939 shs
Average Volume
58,814 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Receive BTMDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for biote and its competitors with MarketBeat's FREE daily newsletter.

BTMDW Stock News Headlines

Here’s How to Claim Your Stake in Elon’s Private Company, xAI
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
Biote: Q4 Earnings Insights
biote A is about to announce its earnings — here's what to expect
See More Headlines

BTMDW Stock Analysis - Frequently Asked Questions

biote's stock was trading at $0.45 at the beginning of 2025. Since then, BTMDW shares have decreased by 95.5% and is now trading at $0.0202.
View the best growth stocks for 2025 here
.

Shares of BTMDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Medicinal Chemicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:BTMDW
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$199.38 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:BTMDW) was last updated on 6/2/2025 by MarketBeat.com Staff
From Our Partners